Cancer Tumor Profiling Market PPT: Trends and Dynamics, Drivers, Competitive landscape and Future Opportunities 2027

1
Global Cancer/Tumor Profiling Market Research and
Forecast Report 2022-2027




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Cancer/Tumor Profiling Market Research
Report 2022-2027 According to the latest report
by IMARC Group, titled "Cancer/Tumor Profiling
Market Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast 2022-2027," the 
global cancer tumor profiling market reached a
value of US 9.38 Billion in 2021. Cancer/tumor
profiling, or biomarker testing, is a process of
identifying specific proteins, genes, gene
mutations (changes), and other biomarkers in a
tumor tissue sample. It assists in determining
whether the pathways of a tumor match up with the
available targeted therapies. It is also used for
therapeutic decision-making, routine diagnostics,
and personalized treatment plans and therapies
based on the severity of the ailment and genomic
build-up. As a result, cancer/tumor profiling
finds extensive applications in the discovery of
biomarkers, research, personalized medicines, and
the development of screening and diagnostic
techniques. Request for a PDF sample of this
report https//www.imarcgroup.com/cancer-tumor-pr
ofiling-market/requestsample

4
Report Description and Highlights
Report Description
Global Cancer/Tumor Profiling Market
Trends The market is primarily driven by the
increasing prevalence of cancer across the globe.
In addition, the growing inclination toward
personalized medicine among the masses represents
another major growth-inducing factor. Besides
this, governments of numerous countries are
investing in cancer research to develop advanced
techniques to reduce the time taken for the
detection and identification of tumors. This,
coupled with the increasing investments by
pharmaceutical and biotechnology companies in
research and development (RD) activities for
introducing novel therapies and new
drug-designing techniques, is positively
influencing the market growth. Furthermore,
recent advancements in molecular biology
techniques, the rising number of clinical trials,
the increasing adoption of immunoassay
techniques, and the developing healthcare
infrastructure across the globe are some of the
other factors creating a positive market outlook
across the globe. Looking forward, IMARC Group
expects the market to reach a value of US 18.22
Billion by 2027, exhibiting a CAGR of 11.20
during the forecast period (2022-2027). View
Report TOC, Figures and Tables
https//www.imarcgroup.com/cancer-tumor-profiling-
market

5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Cancer Type
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Melanoma Cancer
• Others
•  
• Breakup by Technology
• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Immunohistochemistry (IHC)
• In-Situ Hybridization (ISH)
• Microarray
• Others

6
Report Description and Highlights
Report Description

• Breakup by Technique
• Genomics
• Proteomics
• Epigenetics
• Metabolomics
•  
• Breakup by Application
• Personalized Medicine
• Diagnostics
• Biomarker Discovery
• Prognostics
• Others
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

7
Report Description and Highlights
Report Description

•  
• Competitive Landscape with Key Players
• Abbott Laboratories
• Becton Dickinson and Company
• Caris Life Sciences
• Exact Sciences Corporation
• F. Hoffmann-La Roche Ltd
• Hologic Inc
• HTG Molecular Diagnostics Inc
• Illumina Inc
• Laboratory Corporation of America Holdings
• NeoGenomics Laboratories
• Qiagen N.V
• Siemens AG
• Sysmex Corporation
•  

8
Key Questions Answered in the Report
Report Description

• What was the size of the global cancer/tumor
  profiling market in 2021?
• What is the expected growth rate of the global
  cancer/tumor profiling market during 2022-2027?
• What has been the impact of COVID-19 on the
  global cancer/tumor profiling market?
• What are the key factors driving the global
  cancer/tumor profiling market?
• What is the breakup of the global cancer/tumor
  profiling market based on the cancer type?
• What is the breakup of the global cancer/tumor
  profiling market based on the technique?
• What are the key regions in the global
  cancer/tumor profiling market?
• Who are the key players/companies in the global
  cancer/tumor profiling market?
•  

9
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    Global Cancer/Tumor
Profiling Market    5.1    Market Overview   
5.2    Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

10
Table of Contents
Report Description
6    Market Breakup by Cancer Type    6.1  
 Breast Cancer        6.1.1 Market Trends     
  6.1.2 Market Forecast    6.2    Lung Cancer 
      6.2.1 Market Trends        6.2.2 Market
Forecast    6.3    Colorectal Cancer       
6.3.1 Market Trends        6.3.2 Market
Forecast    6.4    Prostate Cancer        6.4.1
Market Trends        6.4.2 Market Forecast   
6.5     Melanoma Cancer        6.5.1 Market
Trends        6.5.2 Market Forecast         
Click here to visit the complete table of
content with list of figures and tables
https//www.imarcgroup.com/cancer-tumor-profiling-
market/toc

11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
14

Contact Us